FDA Approvals

FDA clears first opioid withdrawal deviceFDA granted a new indication to a device that can help reduce the symptoms of withdrawal from the prescription pain drugs.
FDA approves first pill that can be tracked when ingestedFDA approved the first drug in the United States that has a digital ingestion tracking system, which records when the medication was taken.
FDA okays unique injectable for type 2 diabeticsFDA approvedĀ a new once-weekly, single-dose autoinjector device to improve glycemic control in adults with type 2 diabetes.
Shingles vaccine wins approvalFDA approved the herpes zoster vaccine (Shingrix, GlaxoSmithKline) to treat shingles in adults aged 50 years and older.
First Zika test for blood donations wins nod from FDA
Novel device helps diabetics avoid stress linked to glucose testingFDA approved the first continuous glucose monitoring system that allows for diabetes treatment decisions without requiring a fingerstick.
New drug offers hope to advanced breast cancer patientsFDA approved a new treatment for certain breast cancer patients who are not responding to treatment.
FDA alters stance on opioid addiction drugs
FDA alters stance on opioid addiction drugsFDA is advising that these 2 opioid addiction medications should not be withheld from patients taking benzodiazepines or other drugs that depress the central nervous system.
FDA approves generic Tamiflu, plus 2 other new drugs
FDA approves generic Tamiflu, plus 2 other new drugsFDA approved the first generic version of oseltamivir phosphate (Tamiflu, Roche) for oral suspension to treat influenza A and B, plus 2 other noteworthy therapies.
FDA okays biosimilar for several cancers
FDA okays biosimilar for several cancersWhile FDA has approved a handful of biosimilar drugs, the agency just approved the first biosimilar that treats a variety of types of cancer.